Litcius/Paper detail

Prospectively Assessed Long-Term Outcomes of Patients with E-Cigarette– or Vaping-associated Lung Injury

Denitza Blagev, Sean J. Callahan, Dixie Harris, Dave S. Collingridge, Ramona O. Hopkins, Jacqueline R. Eve, Lindsey Waddoups, Valerie Aston, Samuel M. Brown, Michael J. Lanspa

2022Annals of the American Thoracic Society21 citationsDOIOpen Access PDF

Abstract

Abstract Rationale E-cigarette– or vaping-associated lung injury (EVALI) was first identified in 2019. The long-term respiratory, cognitive, mood disorder, and vaping behavior outcomes of patients with EVALI remain unknown. Objectives To determine the long-term respiratory, cognitive, mood disorder, and vaping behavior outcomes of patients with EVALI. Methods We prospectively enrolled patients with EVALI from two health systems. We assessed outcomes at 1 year after onset of EVALI using validated instruments measuring cognitive function, depression, anxiety, post-traumatic stress, respiratory disability, coronavirus disease (COVID-19) infection, pulmonary function, and vaping behaviors. We used multivariable regression to identify risk factors of post-EVALI vaping behaviors and to identify whether admission to the intensive care unit (ICU) was associated with cognitive, respiratory, or mood symptoms. Results Seventy-three patients completed 12-month follow-up. Most patients were male (66.7%), young (mean age, 31 ± 11 yr), and White (85%) and did not need admission to the ICU (59%). At 12 months, 39% (25 of 64) had cognitive impairment, whereas 48% (30 of 62) reported respiratory limitations. Mood disorders were common, with 59% (38 of 64) reporting anxiety and/or depression and 62% (39 of 63) having post-traumatic stress. Four (6.4%) of 64 reported a history of COVID-19 infection. Despite the history of EVALI, many people continued to vape. Only 38% (24 of 64) reported quitting all vaping and smoking behaviors. Younger age was associated with reduced vaping behavior after EVALI (odds ratio, 0.93; P = 0.02). ICU admission was not associated with cognitive impairment, dyspnea, or mood symptoms. Conclusions: Patients with EVALI, despite their youth, commonly have significant long-term respiratory disability; cognitive impairment; symptoms of depression, anxiety, post-traumatic stress; and persistent vaping.

Topics & Concepts

MedicineMoodDepression (economics)AnxietyIntensive care unitOdds ratioInternal medicinePediatricsPsychiatryMacroeconomicsEconomicsChronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory Support and MechanismsSmoking Behavior and Cessation